Over 7 million bacterial genes in the pig gut

Pigs are a main livestock species for food production worldwide and is also widely used as an animal model in biomedical research. Today we know that the many types of bacteria that inhabit the gut are important for health and disease. Knowledge of the genes of these bacteria and their function therefore constitutes the first step towards a more comprehensive understanding of how bacteria in the gut affect health and disease.

An international consortium of researchers from INRA (France), University of Copenhagen and SEGES (Denmark), BGI-Shenzhen (China) and NIFES (Norway) has now established the first catalog of bacterial genes in the gut of pigs. This achievement is published in the latest issue of Nature Microbiology.

The researchers have analyzed stool samples from 287 pigs representing different breeds and selected pig lines from 11 different farms in France, China and Denmark. In total the researchers identified 7.7 million genes and identified a large number of known and unknown bacteria. The results showed clear country dependent differences, reflecting differences in farm systems and antibiotics supplementation. The results further illustrate how age, gender, and pig genetics are associated with differences in the composition of bacteria in the gut.

Importantly, the results also show how the prohibition of the use of antibiotics as growth promotants in Denmark and France seems to have reduced the load of antibiotics resistance genes in the French and Danish pigs, but still, pigs in these countries harbor genes conferring resistance to a large number of antibiotics. The detailed knowledge of the many genes in the gut bacteria will not only be of importance in order to use pigs as a model to elucidate the role of bacteria in relation to many human diseases, but will also be an important tool in the quest towards more sustainable knowledge-based pig farming with the need to combine feed efficiency with resistance to disease, while reducing the use of antibiotics, a main concern in relation to risks of multidrug resistance in humans and animals.